Riskpilot← Back to searchSign inGet full accessNärvård Knäred AB
ABActiveOrg 5591428528Prästgårdsvägen 5General medical practice activities · NACE 8621Est. 201712 employees
Revenue 2024
SEK 15,3M
+13% vs 2023
EBITDA margin
3.1%
+349% vs 2023
Equity ratio
26.2%
Financial strength
Net profit 2024
SEK 269K
+105% vs 2023
| Revenue | SEK 15,3M | +13% |
| EBITDA | SEK 469K | +349% |
| Net profit | SEK 269K | +105% |
| Total assets | SEK 2M | +35% |
| Equity | SEK 516K | +49% |
| Employees | 12 | — |
Legal name
Närvård Knäred AB
Org number
5591428528
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 december 2017
Share capital
SEK 50 000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarvård inom öppenvård samt därmed förenlig verksamhet.
Address
Prästgårdsvägen 5
Email
anders.skoglund@narvardknared.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 174 | 11 720 | 12 712 | 13 586 | 15 339 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 838 | 1 565 | 487 | −188 | 469 |
| Depreciation & amort. | −32 | −65 | −92 | −105 | −112 |
| EBIT | 806 | 1 500 | 395 | −293 | 357 |
| Net financials | −10 | −10 | −18 | −14 | — |
| Profit before tax | 605 | 1 093 | 378 | 180 | 357 |
| Tax | −128 | −245 | −88 | −49 | −88 |
| Net profit | 477 | 848 | 290 | 131 | 269 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 316 | 2 637 | 2 590 | 1 456 | 1 968 |
| Equity | 518 | 1 095 | 785 | 347 | 516 |
| Long-term debt | 166 | 63 | 226 | 4 | 0 |
| Short-term debt | 442 | 891 | 992 | 1 005 | 1 352 |
| Total debt | 608 | 954 | 1 218 | 1 009 | 1 352 |
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
26.2%
This company
38.2%
Market median
-31% vs market
20202024
Return on equity
52.1%
This company
18.4%
Market median
+183% vs market
20202024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20202024
Asset turnover
7.79×
This company
1.12×
Market median
+596% vs market
20202024
Debt / equity
2.81×
This company
0.62×
Market median
-353% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BN | Audit | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Närvård Knäred AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Niklas Sverker Herne | Audit | 0 companies |
| Nils Anders Mikael Skoglund | Board of Directors | 0 companies |
| Lena Mari Skoglund | Deputy Board Member | 0 companies |
| Lena Mari Skoglund | Deputy Board Member | 0 companies |